Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | ESR1 | P03372 | 2/20 | 0.54 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | NT5E | P21589 | 1/20 | 0.48 |
| ▸ | SNCA | P37840 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HTR6 | P50406 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.38 |
| ▸ | PTPRA | P18433 | 1/20 | 0.37 |
| ▸ | PTPRB | P23467 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL996850 | 1.00 | TSHR (0.65) | TSHRSMN1; SMN2CYP2D6POLBTDP1 | |
| SCHEMBL8773415 | 0.98 | TSHR (0.62) | TSHRSMN1; SMN2CYP2D6POLBTDP1 | |
| Water SCHEMBL570669 | 0.98 | TSHR (0.62) | TSHRSMN1; SMN2CYP2D6POLBTDP1 | |
| Water SCHEMBL30394765 | 0.98 | TSHR (0.62) | TSHRSMN1; SMN2CYP2D6POLBTDP1 | |
| Potassium SCHEMBL1450612 | 0.98 | TSHR (0.62) | TSHRSMN1; SMN2CYP2D6POLBTDP1 | |
| SCHEMBL6568428 | 0.98 | TSHR (0.62) | TSHRSMN1; SMN2CYP2D6POLBTDP1 | |
| SCHEMBL8145540 | 0.98 | TSHR (0.62) | TSHRSMN1; SMN2CYP2D6POLBTDP1 | |
| SCHEMBL301148 | 0.98 | TSHR (0.62) | TSHRSMN1; SMN2CYP2D6POLBTDP1 | |
| SCHEMBL6569261 | 0.98 | TSHR (0.62) | TSHRSMN1; SMN2CYP2D6POLBTDP1 | |
| Water SCHEMBL1238257 | 0.96 | TSHR (0.60) | TSHRSMN1; SMN2CYP2D6POLBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731570-A2 | GAMMA-GRAPHYNE AND METHODS OF FABRICATION | CASE WESTERN RESERVE UNIVERSITY (US) | 2026-04-29 | — | — | EP | claimed |
| US-12251401-B2 | Synthesis and antimicrobial uses of dinuclear silver(I) pyrazolates | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2025-03-18 | — | — | US | claimed |
| WO-2024264047-A2 | GAMMA-GRAPHYNE AND METHODS OF FABRICATION | CASE WESTERN RESERVE UNIVERSITY (US) | 2024-12-26 | — | — | WO | claimed |
| EP-4426727-A2 | SPECIFIC CONJUGATION OF AN ANTIBODY | Hangzhou Dac Biotech Co., Ltd. (CN) | 2024-09-11 | — | — | EP | claimed |
| CN-117980327-A | Specific coupling of antibodies | 杭州多禧生物科技有限公司 | 2024-05-03 | — | — | CN | claimed |
| US-20240050469-A1 | Synthesis and Antimicrobial Uses of Dinuclear Silver(I) Pyrazolates | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2024-02-15 | — | — | US | claimed |
| US-11779598-B2 | Synthesis and antimicrobial uses of dinuclear silver(I) pyrazolates | THE FLORIDA INTERNATIONAL UNIVERISTY BOARD OF TRUSTEES (US) | 2023-10-10 | — | — | US | claimed |
| WO-2022078524-A4 | SPECIFIC CONJUGATION OF AN ANTIBODY | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2022-12-08 | — | — | WO | claimed |
| WO-2022078524-A2 | SPECIFIC CONJUGATION OF AN ANTIBODY | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2022-04-21 | — | — | WO | claimed |
| US-20220047628-A1 | Synthesis and Antimicrobial Uses of Dinuclear Silver(I) Pyrazolates | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2022-02-17 | — | — | US | claimed |
| EP-0722432-A1 | METHOD FOR PREPARING OF MONO OR DI-2-SUBSTITUTED CYCLOPENTANONE | RHONE-POULENC AGROCHIMIE (FR) | 1996-07-24 | — | — | EP | claimed |
| EP-0715890-A1 | Electrochemical preparation process of transition metal and phosphine containing catalysts | RHONE-POULENC FIBER & RESIN INTERMEDIATES (FR) | 1996-06-12 | — | — | EP | claimed |
| US-5488129-A | CATALYST SYSTEM CONTAINING TRANSITION METAL COMPOUND, SULFONATED PHOSPHINE, LEWIS ACID | RHONE-POULENC CHIMIE (FR) | 1996-01-30 | — | — | US | claimed |
| US-5486643-A | Isomerization of 2-methyl-3-butenenitrile | RHONE-POULENC CHIMIE (FR) | 1996-01-23 | — | — | US | claimed |
| CN-1108643-A | Method for hydrocyanation of unsatured nitrile into dinitrile | RHONE POULENC CHIMIE (FR) | 1995-09-20 | — | — | CN | claimed |
| EP-0650959-A1 | Hydrocyanation process of unsatured nitriles into dinitriles | RHONE-POULENC FIBER & RESIN INTERMEDIATES (FR) | 1995-05-03 | — | — | EP | claimed |
| WO-1995009830-A1 | METHOD FOR PREPARING OF MONO OR DI-2-SUBSTITUTED CYCLOPENTANONE | RHONE POULENC AGROCHIMIE (FR) | 1995-04-13 | — | — | WO | claimed |
| EP-0647619-A1 | Process for the preparation of 2-methyl-3-butene nitrile | RHONE-POULENC FIBER & RESIN INTERMEDIATES (FR) | 1995-04-12 | — | — | EP | claimed |
| US-RE31812-E | TO ALDEHYDES IN PRESENCE OF CATALYTIC SYSTEM CONTAINING RHODIUM AND SULFONATED ARYL PHOSPHINE COMPOUND | RHONE-POULENC INDUSTRIES (FR) | 1985-01-22 | — | — | US | claimed |
| US-4248802-A | Catalytic hydroformylation of olefins | RHONE-POULENC INDUSTRIES (FR) | 1981-02-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12251401-B2 | Synthesis and antimicrobial uses of dinuclear silver(I) pyrazolates | POLR1C, ZC3HAV1, HELZ | TSHR 3780/4885SMN1; SMN2 4313/4885CYP2D6 2113/4885 |
| US-20220047628-A1 | Synthesis and Antimicrobial Uses of Dinuclear Silver(I) Pyrazolates | POLR1C, ZC3HAV1, HELZ | TSHR 3780/4885SMN1; SMN2 4313/4885CYP2D6 2113/4885 |
| US-20240050469-A1 | Synthesis and Antimicrobial Uses of Dinuclear Silver(I) Pyrazolates | POLR1C, ZC3HAV1, HELZ | TSHR 3780/4885SMN1; SMN2 4313/4885CYP2D6 2113/4885 |
| US-11779598-B2 | Synthesis and antimicrobial uses of dinuclear silver(I) pyrazolates | POLR1C, ZC3HAV1, HELZ | TSHR 3780/4885SMN1; SMN2 4313/4885CYP2D6 2113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.